IRIDEX CORP Files 8-K: Director & Officer Changes
Ticker: IRIX · Form: 8-K · Filed: Apr 3, 2025 · CIK: 1006045
| Field | Detail |
|---|---|
| Company | Iridex Corp (IRIX) |
| Form Type | 8-K |
| Filed Date | Apr 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, governance, officer-appointment
Related Tickers: IRIX
TL;DR
IRIDEX CORP 8-K: New directors elected, officers appointed, and compensation details disclosed.
AI Summary
On April 2, 2025, IRIDEX CORP filed an 8-K report detailing changes in its board of directors and executive officers, including the election of new directors and the appointment of certain officers. The filing also covers compensatory arrangements for these officers. The company is based in Mountain View, California.
Why It Matters
Changes in a company's board and executive team can signal shifts in strategy, governance, or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and executive compensation can introduce uncertainty regarding future strategy and financial performance.
Key Players & Entities
- IRIDEX CORP (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Mountain View, California (location) — Principal executive offices
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors, but specific names and the exact number of new directors are not detailed in this summary section.
Were there any new appointments of certain officers?
Yes, the filing explicitly mentions the appointment of certain officers.
What is the primary business of IRIDEX CORP?
IRIDEX CORP is in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry, SIC code 3845.
When was this 8-K filing submitted?
The filing was submitted on April 3, 2025, reporting events as of April 2, 2025.
What is the company's fiscal year end?
The company's fiscal year ends on December 28.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 3, 2025 regarding IRIDEX CORP (IRIX).